Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Swati Naik

Showing results (41-50 of 92) with videos related to

Pageof 10
Sort By:
The Journal of Biological Chemistry|April 28, 2007
Transcriptional regulation of Cidea, mitochondrial cell death-inducing DNA fragmentation factor alpha-like effector A, in mouse liver by peroxisome proliferator-activated receptor alpha and gammaNavin Viswakarma, Songtao Yu, Swati Naik, et al.
Research Square|October 27, 2023
Acute kidney injury following treatment with CD19-specific CAR T-cell therapy in children, adolescent and young adult patients with B-cell acute lymphoblastic leukemiaYonique P Petgrave, Subodh Selukar, Rebecca Epperly, et al.
Blood Advances|August 18, 2023
CD19 CAR T-cell therapy demonstrates activity against extramedullary disease in pediatric patients with B-ALLRebecca Epperly, Barry L Shulkin, Asim K Bag, et al.
Small (Weinheim an Der Bergstrasse, Germany)|March 16, 2013
Surface assembly and plasmonic properties in strongly coupled segmented gold nanorodsManeesh K Gupta, Tobias König, Rachel Near, et al.
The Journal of Infectious Diseases|May 5, 2017
Characterizing the Cellular Immune Response to Parainfluenza Virus 3Paibel I Aguayo-Hiraldo, Reuben J Arasaratnam, Ifigeneia Tzannou, et al.
Blood Advances|September 26, 2024
EASIX and m-EASIX predict CRS and ICANS in pediatric and AYA patients after CD19-CAR T-cell therapyDua'a Zandaki, Subodh Selukar, Yu Bi, et al.
Haematologica|April 21, 2019
Rapid generation of multivirus-specific T lymphocytes for the prevention and treatment of respiratory viral infectionsSpyridoula Vasileiou, Anne M Turney, Manik Kuvalekar, et al.
Frontiers in Oncology|March 31, 2022
Infectious Complications in Pediatric, Adolescent and Young Adult Patients Undergoing CD19-CAR T Cell TherapyGabriela M Maron, Diego R Hijano, Rebecca Epperly, et al.
Urology|October 30, 2016
Urologic Outcomes of Children With Hemorrhagic Cystitis After Bone Marrow Transplant at a Single InstitutionJason K Au, Christopher Graziano, Rodolfo A Elizondo, et al.
Transplantation and Cellular Therapy|February 22, 2024
Disease Status and Interval between Hematopoietic Cell Transplantations Predict Outcome of Pediatric Patients Who Undergo Subsequent Transplantation for Relapsed Hematologic MalignancyRebecca Epperly, Ying Li, Subodh Selukar, et al.
Pageof 10

Showing results (41-50 of 92) with videos related to

Sort By:
Pageof 10
The Journal of Biological Chemistry|April 28, 2007
Transcriptional regulation of Cidea, mitochondrial cell death-inducing DNA fragmentation factor alpha-like effector A, in mouse liver by peroxisome proliferator-activated receptor alpha and gammaNavin Viswakarma, Songtao Yu, Swati Naik, et al.
Research Square|October 27, 2023
Acute kidney injury following treatment with CD19-specific CAR T-cell therapy in children, adolescent and young adult patients with B-cell acute lymphoblastic leukemiaYonique P Petgrave, Subodh Selukar, Rebecca Epperly, et al.
Blood Advances|August 18, 2023
CD19 CAR T-cell therapy demonstrates activity against extramedullary disease in pediatric patients with B-ALLRebecca Epperly, Barry L Shulkin, Asim K Bag, et al.
Small (Weinheim an Der Bergstrasse, Germany)|March 16, 2013
Surface assembly and plasmonic properties in strongly coupled segmented gold nanorodsManeesh K Gupta, Tobias König, Rachel Near, et al.
The Journal of Infectious Diseases|May 5, 2017
Characterizing the Cellular Immune Response to Parainfluenza Virus 3Paibel I Aguayo-Hiraldo, Reuben J Arasaratnam, Ifigeneia Tzannou, et al.
Blood Advances|September 26, 2024
EASIX and m-EASIX predict CRS and ICANS in pediatric and AYA patients after CD19-CAR T-cell therapyDua'a Zandaki, Subodh Selukar, Yu Bi, et al.
Haematologica|April 21, 2019
Rapid generation of multivirus-specific T lymphocytes for the prevention and treatment of respiratory viral infectionsSpyridoula Vasileiou, Anne M Turney, Manik Kuvalekar, et al.
Frontiers in Oncology|March 31, 2022
Infectious Complications in Pediatric, Adolescent and Young Adult Patients Undergoing CD19-CAR T Cell TherapyGabriela M Maron, Diego R Hijano, Rebecca Epperly, et al.
Urology|October 30, 2016
Urologic Outcomes of Children With Hemorrhagic Cystitis After Bone Marrow Transplant at a Single InstitutionJason K Au, Christopher Graziano, Rodolfo A Elizondo, et al.
Transplantation and Cellular Therapy|February 22, 2024
Disease Status and Interval between Hematopoietic Cell Transplantations Predict Outcome of Pediatric Patients Who Undergo Subsequent Transplantation for Relapsed Hematologic MalignancyRebecca Epperly, Ying Li, Subodh Selukar, et al.
Pageof 10